Japan's Rohto Snaps Up TCM Specialist To Grow In Asia

In a deal worth around $600m, Rohto Pharmaceutical is poised to expand its dietary supplements offering in Southeast Asia through the acquisition of a controlling stake in Singapore's Eu Yan Sang.